Serveur d'exploration Covid

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Nuclear Factor-κB: a Key Regulator in Health and Disease of Lungs

Identifieur interne : 000847 ( Istex/Corpus ); précédent : 000846; suivant : 000848

Nuclear Factor-κB: a Key Regulator in Health and Disease of Lungs

Auteurs : Sanjay Batra ; Gayathriy Balamayooran ; Malaya K. Sahoo

Source :

RBID : ISTEX:CF8357DE3433E4A930444CCE2E0FFF619D9BEAD6

English descriptors

Abstract

Abstract: Rel/NF-κB transcription factors play a key role in modulating the response of immunoregulatory genes including cytokines and chemokines, cell adhesion molecules, acute phase proteins, and anti-microbial peptides. Furthermore, an array of genes important for angiogenesis, tumor invasion and metastasis is also regulated by nuclear factor-κB (NF-κB). Close association of NF-κB with inflammation and tumorigenesis makes it an attractive target for basic research as well as for pharmaceutical industries. Studies involving various animal and cellular models have revealed the importance of NF-κB in pathobiology of lung diseases. This review (a) describes structures, activities, and regulation of NF-κB family members; (b) provides information which implicates NF-κB in pathogenesis of pulmonary inflammation and cancer; and (c) discusses information about available synthetic and natural compounds which target NF-κB or specific components of NF-κB signal transduction pathway and which may provide the foundation for development of effective therapy for lung inflammation and bronchogenic carcinomas.

Url:
DOI: 10.1007/s00005-011-0136-z

Links to Exploration step

ISTEX:CF8357DE3433E4A930444CCE2E0FFF619D9BEAD6

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Nuclear Factor-κB: a Key Regulator in Health and Disease of Lungs</title>
<author>
<name sortKey="Batra, Sanjay" sort="Batra, Sanjay" uniqKey="Batra S" first="Sanjay" last="Batra">Sanjay Batra</name>
<affiliation>
<mods:affiliation>Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, 70803, Baton Rouge, LA, USA</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>E-mail: sbatra@lsu.edu</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Balamayooran, Gayathriy" sort="Balamayooran, Gayathriy" uniqKey="Balamayooran G" first="Gayathriy" last="Balamayooran">Gayathriy Balamayooran</name>
<affiliation>
<mods:affiliation>Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, 70803, Baton Rouge, LA, USA</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Sahoo, Malaya K" sort="Sahoo, Malaya K" uniqKey="Sahoo M" first="Malaya K." last="Sahoo">Malaya K. Sahoo</name>
<affiliation>
<mods:affiliation>Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, 70803, Baton Rouge, LA, USA</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:CF8357DE3433E4A930444CCE2E0FFF619D9BEAD6</idno>
<date when="2011" year="2011">2011</date>
<idno type="doi">10.1007/s00005-011-0136-z</idno>
<idno type="url">https://api.istex.fr/ark:/67375/VQC-XGZ8KBVV-S/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000847</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000847</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Nuclear Factor-κB: a Key Regulator in Health and Disease of Lungs</title>
<author>
<name sortKey="Batra, Sanjay" sort="Batra, Sanjay" uniqKey="Batra S" first="Sanjay" last="Batra">Sanjay Batra</name>
<affiliation>
<mods:affiliation>Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, 70803, Baton Rouge, LA, USA</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>E-mail: sbatra@lsu.edu</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Balamayooran, Gayathriy" sort="Balamayooran, Gayathriy" uniqKey="Balamayooran G" first="Gayathriy" last="Balamayooran">Gayathriy Balamayooran</name>
<affiliation>
<mods:affiliation>Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, 70803, Baton Rouge, LA, USA</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Sahoo, Malaya K" sort="Sahoo, Malaya K" uniqKey="Sahoo M" first="Malaya K." last="Sahoo">Malaya K. Sahoo</name>
<affiliation>
<mods:affiliation>Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, 70803, Baton Rouge, LA, USA</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Archivum Immunologiae et Therapiae Experimentalis</title>
<title level="j" type="abbrev">Arch. Immunol. Ther. Exp.</title>
<idno type="ISSN">0004-069X</idno>
<idno type="eISSN">1661-4917</idno>
<imprint>
<publisher>SP Birkhäuser Verlag Basel</publisher>
<pubPlace>Basel</pubPlace>
<date type="published" when="2011-10-01">2011-10-01</date>
<biblScope unit="volume">59</biblScope>
<biblScope unit="issue">5</biblScope>
<biblScope unit="page" from="335">335</biblScope>
<biblScope unit="page" to="351">351</biblScope>
</imprint>
<idno type="ISSN">0004-069X</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0004-069X</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Cancer</term>
<term>Inflammation</term>
<term>Lung</term>
<term>NF-κB</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Abstract: Rel/NF-κB transcription factors play a key role in modulating the response of immunoregulatory genes including cytokines and chemokines, cell adhesion molecules, acute phase proteins, and anti-microbial peptides. Furthermore, an array of genes important for angiogenesis, tumor invasion and metastasis is also regulated by nuclear factor-κB (NF-κB). Close association of NF-κB with inflammation and tumorigenesis makes it an attractive target for basic research as well as for pharmaceutical industries. Studies involving various animal and cellular models have revealed the importance of NF-κB in pathobiology of lung diseases. This review (a) describes structures, activities, and regulation of NF-κB family members; (b) provides information which implicates NF-κB in pathogenesis of pulmonary inflammation and cancer; and (c) discusses information about available synthetic and natural compounds which target NF-κB or specific components of NF-κB signal transduction pathway and which may provide the foundation for development of effective therapy for lung inflammation and bronchogenic carcinomas.</div>
</front>
</TEI>
<istex>
<corpusName>springer-journals</corpusName>
<author>
<json:item>
<name>Sanjay Batra</name>
<affiliations>
<json:string>Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, 70803, Baton Rouge, LA, USA</json:string>
<json:string>E-mail: sbatra@lsu.edu</json:string>
</affiliations>
</json:item>
<json:item>
<name>Gayathriy Balamayooran</name>
<affiliations>
<json:string>Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, 70803, Baton Rouge, LA, USA</json:string>
</affiliations>
</json:item>
<json:item>
<name>Malaya K. Sahoo</name>
<affiliations>
<json:string>Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, 70803, Baton Rouge, LA, USA</json:string>
</affiliations>
</json:item>
</author>
<subject>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>NF-κB</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Inflammation</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Cancer</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Lung</value>
</json:item>
</subject>
<articleId>
<json:string>136</json:string>
<json:string>s00005-011-0136-z</json:string>
</articleId>
<arkIstex>ark:/67375/VQC-XGZ8KBVV-S</arkIstex>
<language>
<json:string>eng</json:string>
</language>
<originalGenre>
<json:string>ReviewPaper</json:string>
</originalGenre>
<abstract>Abstract: Rel/NF-κB transcription factors play a key role in modulating the response of immunoregulatory genes including cytokines and chemokines, cell adhesion molecules, acute phase proteins, and anti-microbial peptides. Furthermore, an array of genes important for angiogenesis, tumor invasion and metastasis is also regulated by nuclear factor-κB (NF-κB). Close association of NF-κB with inflammation and tumorigenesis makes it an attractive target for basic research as well as for pharmaceutical industries. Studies involving various animal and cellular models have revealed the importance of NF-κB in pathobiology of lung diseases. This review (a) describes structures, activities, and regulation of NF-κB family members; (b) provides information which implicates NF-κB in pathogenesis of pulmonary inflammation and cancer; and (c) discusses information about available synthetic and natural compounds which target NF-κB or specific components of NF-κB signal transduction pathway and which may provide the foundation for development of effective therapy for lung inflammation and bronchogenic carcinomas.</abstract>
<qualityIndicators>
<refBibsNative>false</refBibsNative>
<abstractWordCount>150</abstractWordCount>
<abstractCharCount>1112</abstractCharCount>
<keywordCount>4</keywordCount>
<score>8.8</score>
<pdfWordCount>11067</pdfWordCount>
<pdfCharCount>73750</pdfCharCount>
<pdfVersion>1.3</pdfVersion>
<pdfPageCount>17</pdfPageCount>
<pdfPageSize>595.276 x 790.866 pts</pdfPageSize>
</qualityIndicators>
<title>Nuclear Factor-κB: a Key Regulator in Health and Disease of Lungs</title>
<genre>
<json:string>review-article</json:string>
</genre>
<host>
<title>Archivum Immunologiae et Therapiae Experimentalis</title>
<language>
<json:string>unknown</json:string>
</language>
<publicationDate>2011</publicationDate>
<copyrightDate>2011</copyrightDate>
<issn>
<json:string>0004-069X</json:string>
</issn>
<eissn>
<json:string>1661-4917</json:string>
</eissn>
<journalId>
<json:string>5</json:string>
</journalId>
<volume>59</volume>
<issue>5</issue>
<pages>
<first>335</first>
<last>351</last>
</pages>
<genre>
<json:string>journal</json:string>
</genre>
<subject>
<json:item>
<value>Immunology</value>
</json:item>
<json:item>
<value>Pharmacology/Toxicology</value>
</json:item>
</subject>
</host>
<ark>
<json:string>ark:/67375/VQC-XGZ8KBVV-S</json:string>
</ark>
<publicationDate>2011</publicationDate>
<copyrightDate>2011</copyrightDate>
<doi>
<json:string>10.1007/s00005-011-0136-z</json:string>
</doi>
<id>CF8357DE3433E4A930444CCE2E0FFF619D9BEAD6</id>
<score>1</score>
<fulltext>
<json:item>
<extension>pdf</extension>
<original>true</original>
<mimetype>application/pdf</mimetype>
<uri>https://api.istex.fr/ark:/67375/VQC-XGZ8KBVV-S/fulltext.pdf</uri>
</json:item>
<json:item>
<extension>zip</extension>
<original>false</original>
<mimetype>application/zip</mimetype>
<uri>https://api.istex.fr/ark:/67375/VQC-XGZ8KBVV-S/bundle.zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/ark:/67375/VQC-XGZ8KBVV-S/fulltext.tei">
<teiHeader>
<fileDesc>
<titleStmt>
<title level="a" type="main" xml:lang="en">Nuclear Factor-κB: a Key Regulator in Health and Disease of Lungs</title>
</titleStmt>
<publicationStmt>
<authority>ISTEX</authority>
<publisher scheme="https://scientific-publisher.data.istex.fr">SP Birkhäuser Verlag Basel</publisher>
<pubPlace>Basel</pubPlace>
<availability>
<licence>
<p>L. Hirszfeld Institute of Immunology and Experimental Therapy, Wroclaw, Poland, 2011</p>
</licence>
<p scheme="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-3XSW68JL-F">springer</p>
</availability>
<date>2011-01-07</date>
</publicationStmt>
<notesStmt>
<note type="review-article" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-L5L7X3NF-P">review-article</note>
<note type="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note>
<note>Review</note>
</notesStmt>
<sourceDesc>
<biblStruct type="inbook">
<analytic>
<title level="a" type="main" xml:lang="en">Nuclear Factor-κB: a Key Regulator in Health and Disease of Lungs</title>
<author xml:id="author-0000" corresp="yes">
<persName>
<forename type="first">Sanjay</forename>
<surname>Batra</surname>
</persName>
<email>sbatra@lsu.edu</email>
<affiliation>Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, 70803, Baton Rouge, LA, USA</affiliation>
</author>
<author xml:id="author-0001">
<persName>
<forename type="first">Gayathriy</forename>
<surname>Balamayooran</surname>
</persName>
<affiliation>Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, 70803, Baton Rouge, LA, USA</affiliation>
</author>
<author xml:id="author-0002">
<persName>
<forename type="first">Malaya</forename>
<surname>Sahoo</surname>
</persName>
<affiliation>Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, 70803, Baton Rouge, LA, USA</affiliation>
</author>
<idno type="istex">CF8357DE3433E4A930444CCE2E0FFF619D9BEAD6</idno>
<idno type="ark">ark:/67375/VQC-XGZ8KBVV-S</idno>
<idno type="DOI">10.1007/s00005-011-0136-z</idno>
<idno type="article-id">136</idno>
<idno type="article-id">s00005-011-0136-z</idno>
</analytic>
<monogr>
<title level="j">Archivum Immunologiae et Therapiae Experimentalis</title>
<title level="j" type="abbrev">Arch. Immunol. Ther. Exp.</title>
<idno type="pISSN">0004-069X</idno>
<idno type="eISSN">1661-4917</idno>
<idno type="journal-ID">true</idno>
<idno type="issue-article-count">8</idno>
<idno type="volume-issue-count">6</idno>
<imprint>
<publisher>SP Birkhäuser Verlag Basel</publisher>
<pubPlace>Basel</pubPlace>
<date type="published" when="2011-10-01"></date>
<biblScope unit="volume">59</biblScope>
<biblScope unit="issue">5</biblScope>
<biblScope unit="page" from="335">335</biblScope>
<biblScope unit="page" to="351">351</biblScope>
</imprint>
</monogr>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<creation>
<date>2011-01-07</date>
</creation>
<langUsage>
<language ident="en">en</language>
</langUsage>
<abstract xml:lang="en">
<p>Abstract: Rel/NF-κB transcription factors play a key role in modulating the response of immunoregulatory genes including cytokines and chemokines, cell adhesion molecules, acute phase proteins, and anti-microbial peptides. Furthermore, an array of genes important for angiogenesis, tumor invasion and metastasis is also regulated by nuclear factor-κB (NF-κB). Close association of NF-κB with inflammation and tumorigenesis makes it an attractive target for basic research as well as for pharmaceutical industries. Studies involving various animal and cellular models have revealed the importance of NF-κB in pathobiology of lung diseases. This review (a) describes structures, activities, and regulation of NF-κB family members; (b) provides information which implicates NF-κB in pathogenesis of pulmonary inflammation and cancer; and (c) discusses information about available synthetic and natural compounds which target NF-κB or specific components of NF-κB signal transduction pathway and which may provide the foundation for development of effective therapy for lung inflammation and bronchogenic carcinomas.</p>
</abstract>
<textClass xml:lang="en">
<keywords scheme="keyword">
<list>
<head>Keywords</head>
<item>
<term>NF-κB</term>
</item>
<item>
<term>Inflammation</term>
</item>
<item>
<term>Cancer</term>
</item>
<item>
<term>Lung</term>
</item>
</list>
</keywords>
</textClass>
<textClass>
<keywords scheme="Journal Subject">
<list>
<head>Biomedicine</head>
<item>
<term>Immunology</term>
</item>
<item>
<term>Pharmacology/Toxicology</term>
</item>
</list>
</keywords>
</textClass>
</profileDesc>
<revisionDesc>
<change when="2011-01-07">Created</change>
<change when="2011-10-01">Published</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item>
<extension>txt</extension>
<original>false</original>
<mimetype>text/plain</mimetype>
<uri>https://api.istex.fr/ark:/67375/VQC-XGZ8KBVV-S/fulltext.txt</uri>
</json:item>
</fulltext>
<metadata>
<istex:metadataXml wicri:clean="corpus springer-journals not found" wicri:toSee="no header">
<istex:xmlDeclaration>version="1.0" encoding="UTF-8"</istex:xmlDeclaration>
<istex:docType PUBLIC="-//Springer-Verlag//DTD A++ V2.4//EN" URI="http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd" name="istex:docType"></istex:docType>
<istex:document>
<Publisher>
<PublisherInfo>
<PublisherName>SP Birkhäuser Verlag Basel</PublisherName>
<PublisherLocation>Basel</PublisherLocation>
</PublisherInfo>
<Journal OutputMedium="All">
<JournalInfo JournalProductType="ArchiveJournal" NumberingStyle="Unnumbered">
<JournalID>5</JournalID>
<JournalPrintISSN>0004-069X</JournalPrintISSN>
<JournalElectronicISSN>1661-4917</JournalElectronicISSN>
<JournalTitle>Archivum Immunologiae et Therapiae Experimentalis</JournalTitle>
<JournalAbbreviatedTitle>Arch. Immunol. Ther. Exp.</JournalAbbreviatedTitle>
<JournalSubjectGroup>
<JournalSubject Type="Primary">Biomedicine</JournalSubject>
<JournalSubject Type="Secondary">Immunology</JournalSubject>
<JournalSubject Type="Secondary">Pharmacology/Toxicology</JournalSubject>
</JournalSubjectGroup>
</JournalInfo>
<Volume OutputMedium="All">
<VolumeInfo TocLevels="0" VolumeType="Regular">
<VolumeIDStart>59</VolumeIDStart>
<VolumeIDEnd>59</VolumeIDEnd>
<VolumeIssueCount>6</VolumeIssueCount>
</VolumeInfo>
<Issue IssueType="Regular" OutputMedium="All">
<IssueInfo IssueType="Regular" TocLevels="0">
<IssueIDStart>5</IssueIDStart>
<IssueIDEnd>5</IssueIDEnd>
<IssueArticleCount>8</IssueArticleCount>
<IssueHistory>
<OnlineDate>
<Year>2011</Year>
<Month>9</Month>
<Day>14</Day>
</OnlineDate>
<PrintDate>
<Year>2011</Year>
<Month>9</Month>
<Day>13</Day>
</PrintDate>
<CoverDate>
<Year>2011</Year>
<Month>10</Month>
</CoverDate>
<PricelistYear>2011</PricelistYear>
</IssueHistory>
<IssueCopyright>
<CopyrightHolderName>L. Hirszfeld Institute of Immunology and Experimental Therapy, Wroclaw, Poland</CopyrightHolderName>
<CopyrightYear>2011</CopyrightYear>
</IssueCopyright>
</IssueInfo>
<Article ID="s00005-011-0136-z" OutputMedium="All">
<ArticleInfo ArticleType="ReviewPaper" ContainsESM="No" Language="En" NumberingStyle="Unnumbered" TocLevels="0">
<ArticleID>136</ArticleID>
<ArticleDOI>10.1007/s00005-011-0136-z</ArticleDOI>
<ArticleCitationID>335</ArticleCitationID>
<ArticleSequenceNumber>3</ArticleSequenceNumber>
<ArticleTitle Language="En" OutputMedium="All">Nuclear Factor-κB: a Key Regulator in Health and Disease of Lungs</ArticleTitle>
<ArticleCategory>Review</ArticleCategory>
<ArticleFirstPage>335</ArticleFirstPage>
<ArticleLastPage>351</ArticleLastPage>
<ArticleHistory>
<RegistrationDate>
<Year>2011</Year>
<Month>7</Month>
<Day>7</Day>
</RegistrationDate>
<Received>
<Year>2011</Year>
<Month>1</Month>
<Day>7</Day>
</Received>
<Accepted>
<Year>2011</Year>
<Month>3</Month>
<Day>2</Day>
</Accepted>
<OnlineDate>
<Year>2011</Year>
<Month>7</Month>
<Day>26</Day>
</OnlineDate>
</ArticleHistory>
<ArticleCopyright>
<CopyrightHolderName>L. Hirszfeld Institute of Immunology and Experimental Therapy, Wroclaw, Poland</CopyrightHolderName>
<CopyrightYear>2011</CopyrightYear>
</ArticleCopyright>
<ArticleGrants Type="Regular">
<MetadataGrant Grant="OpenAccess"></MetadataGrant>
<AbstractGrant Grant="OpenAccess"></AbstractGrant>
<BodyPDFGrant Grant="Restricted"></BodyPDFGrant>
<BodyHTMLGrant Grant="Restricted"></BodyHTMLGrant>
<BibliographyGrant Grant="Restricted"></BibliographyGrant>
<ESMGrant Grant="Restricted"></ESMGrant>
</ArticleGrants>
</ArticleInfo>
<ArticleHeader>
<AuthorGroup>
<Author AffiliationIDS="Aff1" CorrespondingAffiliationID="Aff1">
<AuthorName DisplayOrder="Western">
<GivenName>Sanjay</GivenName>
<FamilyName>Batra</FamilyName>
</AuthorName>
<Contact>
<Email>sbatra@lsu.edu</Email>
</Contact>
</Author>
<Author AffiliationIDS="Aff1">
<AuthorName DisplayOrder="Western">
<GivenName>Gayathriy</GivenName>
<FamilyName>Balamayooran</FamilyName>
</AuthorName>
</Author>
<Author AffiliationIDS="Aff1">
<AuthorName DisplayOrder="Western">
<GivenName>Malaya</GivenName>
<GivenName>K.</GivenName>
<FamilyName>Sahoo</FamilyName>
</AuthorName>
</Author>
<Affiliation ID="Aff1">
<OrgDivision>Department of Pathobiological Sciences, School of Veterinary Medicine</OrgDivision>
<OrgName>Louisiana State University</OrgName>
<OrgAddress>
<City>Baton Rouge</City>
<State>LA</State>
<Postcode>70803</Postcode>
<Country Code="US">USA</Country>
</OrgAddress>
</Affiliation>
</AuthorGroup>
<Abstract ID="Abs1" Language="En" OutputMedium="All">
<Heading>Abstract</Heading>
<Para TextBreak="No">Rel/NF-κB transcription factors play a key role in modulating the response of immunoregulatory genes including cytokines and chemokines, cell adhesion molecules, acute phase proteins, and anti-microbial peptides. Furthermore, an array of genes important for angiogenesis, tumor invasion and metastasis is also regulated by nuclear factor-κB (NF-κB). Close association of NF-κB with inflammation and tumorigenesis makes it an attractive target for basic research as well as for pharmaceutical industries. Studies involving various animal and cellular models have revealed the importance of NF-κB in pathobiology of lung diseases. This review (a) describes structures, activities, and regulation of NF-κB family members; (b) provides information which implicates NF-κB in pathogenesis of pulmonary inflammation and cancer; and (c) discusses information about available synthetic and natural compounds which target NF-κB or specific components of NF-κB signal transduction pathway and which may provide the foundation for development of effective therapy for lung inflammation and bronchogenic carcinomas.</Para>
</Abstract>
<KeywordGroup Language="En" OutputMedium="All">
<Heading>Keywords</Heading>
<Keyword>NF-κB</Keyword>
<Keyword>Inflammation</Keyword>
<Keyword>Cancer</Keyword>
<Keyword>Lung</Keyword>
</KeywordGroup>
</ArticleHeader>
<NoBody></NoBody>
</Article>
</Issue>
</Volume>
</Journal>
</Publisher>
</istex:document>
</istex:metadataXml>
<mods version="3.6">
<titleInfo lang="en">
<title>Nuclear Factor-κB: a Key Regulator in Health and Disease of Lungs</title>
</titleInfo>
<titleInfo type="alternative" contentType="CDATA">
<title>Nuclear Factor-κB: a Key Regulator in Health and Disease of Lungs</title>
</titleInfo>
<name type="personal" displayLabel="corresp">
<namePart type="given">Sanjay</namePart>
<namePart type="family">Batra</namePart>
<affiliation>Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, 70803, Baton Rouge, LA, USA</affiliation>
<affiliation>E-mail: sbatra@lsu.edu</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Gayathriy</namePart>
<namePart type="family">Balamayooran</namePart>
<affiliation>Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, 70803, Baton Rouge, LA, USA</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Malaya</namePart>
<namePart type="given">K.</namePart>
<namePart type="family">Sahoo</namePart>
<affiliation>Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, 70803, Baton Rouge, LA, USA</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre type="review-article" displayLabel="ReviewPaper" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-L5L7X3NF-P">review-article</genre>
<originInfo>
<publisher>SP Birkhäuser Verlag Basel</publisher>
<place>
<placeTerm type="text">Basel</placeTerm>
</place>
<dateCreated encoding="w3cdtf">2011-01-07</dateCreated>
<dateIssued encoding="w3cdtf">2011-10-01</dateIssued>
<copyrightDate encoding="w3cdtf">2011</copyrightDate>
</originInfo>
<language>
<languageTerm type="code" authority="rfc3066">en</languageTerm>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</language>
<abstract lang="en">Abstract: Rel/NF-κB transcription factors play a key role in modulating the response of immunoregulatory genes including cytokines and chemokines, cell adhesion molecules, acute phase proteins, and anti-microbial peptides. Furthermore, an array of genes important for angiogenesis, tumor invasion and metastasis is also regulated by nuclear factor-κB (NF-κB). Close association of NF-κB with inflammation and tumorigenesis makes it an attractive target for basic research as well as for pharmaceutical industries. Studies involving various animal and cellular models have revealed the importance of NF-κB in pathobiology of lung diseases. This review (a) describes structures, activities, and regulation of NF-κB family members; (b) provides information which implicates NF-κB in pathogenesis of pulmonary inflammation and cancer; and (c) discusses information about available synthetic and natural compounds which target NF-κB or specific components of NF-κB signal transduction pathway and which may provide the foundation for development of effective therapy for lung inflammation and bronchogenic carcinomas.</abstract>
<note>Review</note>
<subject lang="en">
<genre>Keywords</genre>
<topic>NF-κB</topic>
<topic>Inflammation</topic>
<topic>Cancer</topic>
<topic>Lung</topic>
</subject>
<relatedItem type="host">
<titleInfo>
<title>Archivum Immunologiae et Therapiae Experimentalis</title>
</titleInfo>
<titleInfo type="abbreviated">
<title>Arch. Immunol. Ther. Exp.</title>
</titleInfo>
<genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre>
<originInfo>
<publisher>Springer</publisher>
<dateIssued encoding="w3cdtf">2011-09-14</dateIssued>
<copyrightDate encoding="w3cdtf">2011</copyrightDate>
</originInfo>
<subject>
<genre>Biomedicine</genre>
<topic>Immunology</topic>
<topic>Pharmacology/Toxicology</topic>
</subject>
<identifier type="ISSN">0004-069X</identifier>
<identifier type="eISSN">1661-4917</identifier>
<identifier type="JournalID">5</identifier>
<identifier type="IssueArticleCount">8</identifier>
<identifier type="VolumeIssueCount">6</identifier>
<part>
<date>2011</date>
<detail type="volume">
<number>59</number>
<caption>vol.</caption>
</detail>
<detail type="issue">
<number>5</number>
<caption>no.</caption>
</detail>
<extent unit="pages">
<start>335</start>
<end>351</end>
</extent>
</part>
<recordInfo>
<recordOrigin>L. Hirszfeld Institute of Immunology and Experimental Therapy, Wroclaw, Poland, 2011</recordOrigin>
</recordInfo>
</relatedItem>
<identifier type="istex">CF8357DE3433E4A930444CCE2E0FFF619D9BEAD6</identifier>
<identifier type="ark">ark:/67375/VQC-XGZ8KBVV-S</identifier>
<identifier type="DOI">10.1007/s00005-011-0136-z</identifier>
<identifier type="ArticleID">136</identifier>
<identifier type="ArticleID">s00005-011-0136-z</identifier>
<accessCondition type="use and reproduction" contentType="copyright">L. Hirszfeld Institute of Immunology and Experimental Therapy, Wroclaw, Poland, 2011</accessCondition>
<recordInfo>
<recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-3XSW68JL-F">springer</recordContentSource>
<recordOrigin>L. Hirszfeld Institute of Immunology and Experimental Therapy, Wroclaw, Poland, 2011</recordOrigin>
</recordInfo>
</mods>
<json:item>
<extension>json</extension>
<original>false</original>
<mimetype>application/json</mimetype>
<uri>https://api.istex.fr/ark:/67375/VQC-XGZ8KBVV-S/record.json</uri>
</json:item>
</metadata>
<serie></serie>
</istex>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000847 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 000847 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    CovidV1
   |flux=    Istex
   |étape=   Corpus
   |type=    RBID
   |clé=     ISTEX:CF8357DE3433E4A930444CCE2E0FFF619D9BEAD6
   |texte=   Nuclear Factor-κB: a Key Regulator in Health and Disease of Lungs
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Fri Mar 27 18:14:15 2020. Site generation: Sun Jan 31 15:15:08 2021